Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Optical coherence tomography (OCT) can successfully identify the characteristics of coronary plaques

A catheter-based imaging technology called optical coherence tomography (OCT) can successfully identify the characteristics of coronary plaques in patients with various cardiac symptoms. The report from researchers at Massachusetts General Hospital (MGH) will appear in the journal Circulation.

29 Mar 2005

Heart attacks can be triggered by physical exertion and emotional stress

Philip Strike and Andrew Steptoe of University College London, in a review published in the current issue of Psychosomatic Medicine, of dozens of studies done between 1970 and 2004 have come up with compelling evidence that indicates that people with a history of heart disease, can trigger heart attacks, some of them fatal, by physical exertion and emotional stress.

23 Mar 2005

First patient to test new treatment for peripheral arterial disease

For several years, crippling leg pain has prevented Joan Erickson from walking more than a block. If she paused to rest, she could walk a little more, but not enough to continue playing golf, her favorite pastime.

23 Mar 2005

Physical exertion and emotional stress can trigger heart attacks in people with a history of heart disease

Authors Philip Strike and Andrew Steptoe of University College London point out that the triggers for heart attacks may be quite different from the factors that lead to development of coronary heart disease over the long term, such as cigarette smoking, lack of exercise, work stress, social isolation, anxiety and depression.

22 Mar 2005

More research on Vitamin E surprises scientists

50 years of research into the supposed benefits of taking vitamin E has extolled its antioxidant potential to offer a variety of potential health benefits, including reducing the risk of Alzheimer's, cancer and heart disease.

15 Mar 2005

Vasogen granted European patent in chronic heart failure

Vasogen today announced that it has been granted a European patent covering the use of its Celacade technology for the treatment of chronic heart failure, and has completed the registration procedure to bring it fully into force in all the major countries of Europe including the U.K., France, Germany, Spain, Italy, and Sweden.

15 Mar 2005

New insight into key mechanism by which cells limit cholesterol

The finding suggests a novel approach to the development of cholesterol-lowering drugs that may boost the effect of statins, one of the most prescribed cholesterol inhibitors, according to researchers at the University of Texas Southwestern Medical Center.

15 Mar 2005

Community care tops medical care at preventing heart disease in black Americans

Upgraded community health services, including checkups by phone or in person with a local nurse practitioner at a neighborhood clinic, and free charge cards for medications are almost nine times more likely to benefit black Americans at greater risk of heart disease than full-service physician care alone.

15 Mar 2005

Obesity among African-American stroke survivors increases risk factors for recurrent stroke

Obesity may put African-Americans who have survived one stroke at risk for a second stroke by increasing their risk of hypertension (high blood pressure), diabetes and high cholesterol, according to an article in the March issue of Archives of Neurology, one of the JAMA/Archives journals.

14 Mar 2005

High prevalence of hostility symptoms in young coronary artery disease patients

Young coronary artery disease patients have a higher prevalence of hostility than older patients with the disease, researchers explain in the current issue of Mayo Clinic Proceedings. The authors say reducing hostility in these patients should be part of a rehabilitation program.

14 Mar 2005

HIV is not an independent risk factor for severe heart disease

Infection with human immunodeficiency virus (HIV) is no longer an automatic death sentence, thanks to the use of highly active anti-retroviral therapy (HAART).

8 Mar 2005

Pet scanning could cut use of angiograms and bypass surgery, as well as patient costs

Using positron emission tomography (PET) scanning rather than other types of imaging as the first tool to diagnose heart-vessel blockages is more accurate, less invasive and saves dollars, a study by a University at Buffalo team has shown.

8 Mar 2005

Study finds potential link to help find blocked heart arteries

A blood test in combination with a stress test can help better determine if someone is likely to have a blocked heart artery, according to a study by doctors at Providence Hospital in Southfield, Mich.

8 Mar 2005

Beta-blockers can benefit patients with certain serious heart problems such as diastolic heart failure

Beta-blockers, medications that block the action of certain hormones on the heart, can benefit patients with certain serious heart problems such as diastolic heart failure, according to cardiologists at the Keck School of Medicine of the University of Southern California and Loma Linda University Medical Center.

7 Mar 2005

Implanted devices are giving cardiologists a new view of subtle changes in a key measurement of heart health

Implanted devices intended to optimize the cardiac function of patients with heart failure have provided new insights into which patients might be at higher risk of dying suddenly from their disease, according to researchers at Duke University Medical Center.

7 Mar 2005

Breakthrough noninvasive tool for early cardiovascular disease detection

Physicians and researchers now have access to a noninvasive fingertip test that can identify patients with the earliest stages of cardiovascular disease and replace testing that is done during angiography.

7 Mar 2005

Studies find Aspirin resistance in up to 27% of Aspirin users

While aspirin remains a crucial and cost-effective therapy for the prevention and management of cardiovascular diseases, research suggests that a significant percentage of the 25 million Americans on a chronic aspirin regimen are "aspirin resistant," or do not achieve sufficient antiplatelet effects from aspirin.

7 Mar 2005

HAART saves 2 million life years

The total impact of HIV treatment in the US has been evaluated for the first time. Dr. Rochelle Walensky, ( Harvard Medical School in Boston), speaking at the 12th Annual Retrovirus Conference, quoted from research which estimated the survival benefits of highly active antiretroviral therapy (HAART) and opportunistic infection prophylaxis in the US from 1989 to 2003.

2 Mar 2005

Small hearts make big difference for young transplant recipients

When a young child is in need of a heart transplant, the problem is not the intricate surgery, but the scarcity of donors.

1 Mar 2005

Growing evidence base supports focus on mind-body connection in heart disease

Cardiologists should recognize and help manage depression, stress and other common psychosocial risk factors that play a powerful role in the wellbeing and health outcomes of heart disease patients, according to an article(PDF) in the March 1, 2005 issue of the Journal of the American College of Cardiology.

1 Mar 2005